BOLD
Boundless Bio, Inc.
There isn't enough reported data to score BOLD yet.
BOLD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BOLD's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
BOLD PE Valuation
BOLD has no meaningful PE right now: it lost money over the past year.
BOLD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect BOLD's losses to shrink, with revenue holding steady.
BOLD Earnings Per Share
BOLD lost $2.46 per share over the past year, a bigger loss than the year before.
BOLD Quarterly Revenue
BOLD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.9M | -$672K |
| Q2 2026 | -$21M | -$9.1M |
| Q1 2026 | -$15M | -$391K |
| Q4 2025 | -$10.5M | +$5.5M |
| Q3 2025 | -$10.2M | +$3.5M |
| Q2 2025 | -$11.9M | +$5.9M |
| Q1 2025 | -$14.6M | +$1.3M |
| Q4 2024 | -$16M | -$4.1M |
BOLD has burned cash in almost every quarter: −$57M over the past year, against −$53M the year before.
BOLD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +415K shares |
| 1 year | +2.1% | +479K shares |
| 3 years | +2.8% | +626K shares |
BOLD has 23M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
BOLD Net Leverage
BOLD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BOLD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 20.8 | Neutral |
BOLD's weekly RSI is 55 (neutral) and its Stochastic is 21 (neutral).
BOLD PE vs Healthcare Sector
BOLD has no meaningful PE right now: it lost money over the past year.
BOLD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.49 | 1.2% below |
| 20 week MA | $2.62 | 6.1% below |
| 50 week MA | $1.84 | 34% above |
| 100 week MA | $1.68 | 46% above |
BOLD has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 46% above its 100-week average.
BOLD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $14.3 | $2.55 | -82% |
| 2025 | $2.55 | $1.20 | -53% |
| 2026 YTD | $1.20 | $2.46 | +105% |
BOLD has finished every year since 2024 lower, and it's up 105% so far in 2026.